UCHL5 and cancer: As a target molecule of UCHL5, NFRKB is protected from ubiquitination degradation by UCHL5 and plays an important role in DNA double-strand break (DSB) resection and repair by homologous recombination, and is regarded as a potential therapeutic target for cancer [27, 28], but the mechanism remains to be investigated.